As we enter the Bio Century, AI innovations are becoming pivotal in shaping the future of biology and medicine. In this episode, I am joined by Micha Breakstone, the founder and CEO of Somite.ai, who is at the forefront of integrating AI with stem cell biology. Together, we explore the intersection of AI and health, its history, and its impact on startups and enterprises alike.
Episode Highlights
- AI innovations are transforming biology and medicine, paving the way for revolutionary advances in disease understanding, diagnostics, and treatments.
- Somite.ai, aiming to be the OpenAI for stem cells, is developing a platform to map cell trajectories and guide pluripotent stem cells to become targeted cells for therapeutic use.
- AlphaFold's understanding of protein folding represented a major breakthrough, deepening our scientific understanding and serving as a clear example of AI’s potential impact on biology.
- The evolving landscape is creating tension between traditional asset-focused strategies and AI-driven platform business models, prompting questions about where the true value of these companies lies.
- What's Next, Austin?
- "I would absolutely love to see Austin become a force of nature in moving innovation forward."
What is Austin Next?
Austin's transformation into a global innovation powerhouse is at the heart of Austin Next. We explore insights into the region's evolution and the building of robust ecosystems. Additionally, we delve into the potential impact of emerging trends, technologies, and their convergence.
Austin, as our real-world case study, helps us aspire to better comprehend the true nature of innovation.